Endothelial progenitor cells for postnatal vasculogenesis
- PMID: 15308462
- DOI: 10.1152/ajpcell.00330.2003
Endothelial progenitor cells for postnatal vasculogenesis
Abstract
In the past decade, researchers have defined committed stem or progenitor cells from various tissues, including bone marrow, peripheral blood, brain, liver, and reproductive organs, in both adult animals and humans. Whereas most cells in adult organs are composed of differentiated cells, which express a variety of specific phenotypic genes adapted to each organ's environment, quiescent stem or progenitor cells are maintained locally or in the systemic circulation and are activated by environmental stimuli for physiological and pathological tissue regeneration. Recently, endothelial progenitor cells (EPCs) were isolated from peripheral blood CD34, Flk-1, or AC133 antigen-positive cells, which are considered to include a hematopoietic stem cell population, and were shown to be incorporated into foci of neovascularization. This finding, that circulating EPCs may home to sites of neovascularization and differentiate into endothelial cells in situ, is consistent with "vasculogenesis," a critical paradigm for embryonic neovascularization, and suggests that vasculogenesis and angiogenesis may constitute complementary mechanisms for postnatal neovascularization. Previous reports demonstrating therapeutic potential of EPC transplantation in animal models of hindlimb and myocardial ischemia opened the way to the clinical application of cell therapy: the replacement of diseased or degenerating cell populations, tissues, and organs. In this review, we summarize biological features of EPCs and speculate on the utility of EPCs for vascular and general medicine.
Similar articles
-
Therapeutic potential of endothelial progenitor cells for cardiovascular diseases.Curr Vasc Pharmacol. 2006 Jan;4(1):59-65. doi: 10.2174/157016106775203063. Curr Vasc Pharmacol. 2006. PMID: 16472177 Review.
-
Angiogenesis and vasculogenesis for therapeutic neovascularization.Nagoya J Med Sci. 2003 May;66(1-2):1-7. Nagoya J Med Sci. 2003. PMID: 12848416 Review.
-
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.Circ Res. 1999 Aug 6;85(3):221-8. doi: 10.1161/01.res.85.3.221. Circ Res. 1999. PMID: 10436164
-
Cell therapy and gene therapy using endothelial progenitor cells for vascular regeneration.Handb Exp Pharmacol. 2007;(180):181-94. doi: 10.1007/978-3-540-68976-8_8. Handb Exp Pharmacol. 2007. PMID: 17554509 Review.
-
[Vascular regeneration].Nihon Rinsho. 2008 May;66(5):899-907. Nihon Rinsho. 2008. PMID: 18464508 Review. Japanese.
Cited by
-
Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.Neuromuscul Disord. 2013 Jan;23(1):75-83. doi: 10.1016/j.nmd.2012.09.003. Epub 2012 Oct 9. Neuromuscul Disord. 2013. PMID: 23058947 Free PMC article.
-
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.J Cell Mol Med. 2007 Sep-Oct;11(5):981-1011. doi: 10.1111/j.1582-4934.2007.00088.x. J Cell Mol Med. 2007. PMID: 17979879 Free PMC article. Review.
-
Coding Cell Identity of Human Skeletal Muscle Progenitor Cells Using Cell Surface Markers: Current Status and Remaining Challenges for Characterization and Isolation.Front Cell Dev Biol. 2019 Nov 26;7:284. doi: 10.3389/fcell.2019.00284. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31828070 Free PMC article. Review.
-
Canonical Wnt Signaling Promotes Neovascularization Through Determination of Endothelial Progenitor Cell Fate via Metabolic Profile Regulation.Stem Cells. 2019 Oct;37(10):1331-1343. doi: 10.1002/stem.3049. Epub 2019 Jul 22. Stem Cells. 2019. PMID: 31233254 Free PMC article.
-
Syndecan-4 and stromal cell-derived factor-1 alpha functionalized endovascular scaffold facilitates adhesion, spreading and differentiation of endothelial colony forming cells and functions under flow and shear stress conditions.J Biomed Mater Res B Appl Biomater. 2023 Mar;111(3):538-550. doi: 10.1002/jbm.b.35170. Epub 2022 Oct 8. J Biomed Mater Res B Appl Biomater. 2023. PMID: 36208170 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous